Rubius Recruiting Adults with Phenylketonuria to Test its RTX-134 Cell Therapy
News
Rubius Therapeutics is currently recruiting patients for its Phase 1b clinical trial that will evaluate the safety and early efficacy of RTX-134, its investigational cell therapy for phenylketonuria. RTX-134 uses ... Read more